GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences: Monitoring Agency Report on Rs. 600 Crore Preferential Issue

FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 04 Nov 2026, 08:55 PM IST  ·  BSE ID: db76f01c-fadf-4a1e-8a21-97ac4b1f35fd
View Original BSE Filing (PDF)
💡
In Simple Terms
The company submitted a report confirming that money raised from selling warrants to promoters has been used as planned.
🤖 AI Summary
  • Krishna Institute of Medical Sciences reports on Rs. 600 crore preferential issue of warrants.
  • Monitoring Agency Report covers quarter ending September 30, 2026.
  • CARE Ratings Limited serves as the Monitoring Agency for the issue.
  • No deviation from the stated objects of the issue was noted.
  • Funds utilization is monitored as per SEBI regulations.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Issue Size
Rs. 600 crores
Quarter Ended
September 30, 2026
Issue Period
18 months (ending February 18, 2028)
🏢 How This Affects the Company
💰
Financial Impact
This filing confirms adherence to the planned use of funds from the preferential issue, providing financial transparency to stakeholders regarding the Rs. 600 crore raised.
⚠️
Risk Impact
The absence of deviation from stated objects reduces the risk associated with fund mismanagement, upholding the integrity of the capital raising exercise.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this report.
👤
Who Is Affected
All shareholders are informed by this report regarding the proper utilization of funds raised through the preferential issue.
🔍
Management Signal
This filing signals management's commitment to transparency and regulatory compliance in fund deployment.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Next quarterly Monitoring Agency Report for the preferential issue.
Company's financial results for subsequent quarters.
Update on the utilization of the remaining issue proceeds.
LOW RISK The report confirms compliance and no deviation in fund utilization.
💡 Investor Takeaway
Krishna Institute of Medical Sciences' Monitoring Agency Report for Q2 FY27 confirms no deviation in the utilization of Rs. 600 crore preferential issue funds, as reviewed by CARE Ratings Limited.
⚖️ Strengths & Concerns

✅ Positives

  • Confirmation of Rs. 600 crore preferential issue proceeds utilization aligning with stated objectives.
  • Adherence to SEBI regulations for monitoring of issue proceeds by an independent agency.
📅 Company Track Record
Previous filings show KIMS raised Rs. 15,000 million via QIP in June 2026 and approved a Rs. 5,999.99 million preferential allotment of warrants to promoters in June 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the Monitoring Agency Report filed by Krishna Institute of Medical Sciences Ltd?
The company filed a Monitoring Agency Report from CARE Ratings Limited for the quarter ended September 30, 2026, concerning its Rs. 600 crore preferential issue of warrants.
Was there any deviation in the utilization of funds from the preferential issue?
No, the report states that there was Nil deviation from the objects of the preferential issue for the quarter ended September 30, 2026.
What is the total size of the preferential issue being monitored?
The preferential issue being monitored aggregates to Rs. 600 crores, comprising warrants convertible into equity shares.
Who is the Monitoring Agency for Krishna Institute of Medical Sciences' preferential issue?
CARE Ratings Limited is the appointed Monitoring Agency for the preferential issue of Krishna Institute of Medical Sciences Limited.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.